表紙:プレシジョンメディシンの世界市場(2023年~2033年)
市場調査レポート
商品コード
1302960

プレシジョンメディシンの世界市場(2023年~2033年)

Precision Medicine Market Report 2023-2033

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 347 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=195.22円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

プレシジョンメディシンの世界市場(2023年~2033年)
出版日: 2023年06月29日
発行: Visiongain Reports Ltd.
ページ情報: 英文 347 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプレシジョンメディシンの市場規模は、2033年までに11.0%のCAGRで成長すると予測されています。プレシジョンメディシンの用途拡大と標的治療への需要の高まりは、市場の成長を促進していると考えられます。

当レポートでは、世界のプレシジョンメディシン市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • SWOT分析
  • PEST分析

第4章 プレシジョンメディシン市場分析:製品タイプ別

  • 主な調査結果
  • 製品タイプセグメント:市場魅力度指数
  • プレシジョンメディシン市場規模の推定と予測:製品タイプ別
  • 診断
    • 遺伝子検査
    • バイオマーカーに基づく検査
    • その他
  • 治療

第5章 プレシジョンメディシン市場分析:用途別

  • 主な調査結果
  • 用途セグメント:市場魅力度指数
  • プレシジョンメディシン市場規模の推定と予測:用途別
  • 腫瘍
  • 中枢神経系
  • 免疫
  • 呼吸器系
  • その他

第6章 プレシジョンメディシン市場分析:技術別

  • 主な調査結果
  • 技術セグメント:市場魅力度指数
  • プレシジョンメディシン市場規模の推定と予測:技術別
  • 創薬
  • バイオインフォマティクス
  • ビッグデータ分析
  • 遺伝子配列決定
  • コンパニオン診断
  • その他

第7章 プレシジョンメディシン市場分析:エンドユーザー別

  • 主な調査結果
  • エンドユーザーセグメント:市場魅力度指数
  • プレシジョンメディシン市場規模の推定と予測:エンドユーザー別
  • 病院
  • 診断センター
  • 研究および学術機関
  • その他

第8章 プレシジョンメディシン市場分析:地域別

  • 主な調査結果
  • 地域の市場規模の推定と予測

第9章 北米のプレシジョンメディシン市場分析

第10章 欧州のプレシジョンメディシン市場分析

第11章 アジア太平洋のプレシジョンメディシン市場分析

第12章 ラテンアメリカのプレシジョンメディシン市場分析

第13章 中東・アフリカのプレシジョンメディシン市場分析

第14章 企業プロファイル

  • 競合情勢(2022年)
  • Pfizer Inc.
  • Qiagen
  • Quest Diagnostics Incorporated
  • Agilent Technologies Inc.
  • Illumina, Inc.
  • Novartis AG
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Lilly
  • Thermo Fisher Scientific Inc.
  • AstraZeneca
  • Myriad Genetics Inc
  • GSK plc
  • Bristol-Myers Squibb Company
  • Danaher
  • Laboratory Corporation of America Holdings
  • GE HealthCare
  • Teva Pharmaceutical Industries Ltd.
  • NanoString Technologies, Inc.
  • Bayer AG
  • Biogen
  • Johnson &Johnson Services, Inc.

第15章 結論と推奨事項

  • 結論
  • 市場参入企業への推奨事項
図表

List of Tables

  • Table 1 Precision Medicine Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
  • Table 2 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 7 Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 8 Genetic Tests Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 9 Biomarker Based Tests Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 10 Others Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 11 Therapeutics Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 12 Precision Medicine Market by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 13 Oncology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 14 CNS Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 15 Immunology Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 16 Respiratory Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 17 Others Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 18 Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 19 Drug Discovery Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 20 Bioinformatics Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 21 Big Data Analytics Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 22 Gene Sequencing Market Forecast by Region, 2023-2033 (US$ bn, AGR%, CAGR%)
  • Table 23 Companion Diagnostics Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 24 Other Technologies Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 25 Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 26 Hospitals Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 27 Diagnostic Centres Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 28 Research & academic institutes Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 29 Other End-users Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 30 Precision Medicine Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 31 North America Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 32 North America Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 33 North America Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 34 North America Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 35 North America Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 36 U.S. Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 37 Canada Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 38 Europe Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 39 Europe Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 40 Europe Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 41 Europe Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 42 Europe Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 43 Germany Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 44 UK Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 45 France Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 46 Italy Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 47 Spain Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 48 Switzerland Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 49 Netherlands Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 50 Rest of Europe Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 51 Asia Pacific Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 52 Asia Pacific Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 53 Asia Pacific Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 54 Asia Pacific Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 55 Asia Pacific Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 56 Japan Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 57 China Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 58 India Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 59 Australia Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 60 South Korea Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 61 Singapore Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 62 Rest of Asia Pacific Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 63 Latin America Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 64 Latin America Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 65 Latin America Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 66 Latin America Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 67 Latin America Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 68 Brazil Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 69 Mexico Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 70 Argentina Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 71 Rest of Latin America Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 72 MEA Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 73 MEA Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 74 MEA Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 75 MEA Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 76 MEA Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 77 GCC Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 78 South Africa Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 79 Egypt Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 80 Rest of MEA Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
  • Table 81 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 Pfizer Inc.: Product Benchmarking
  • Table 83 Pfizer Inc.: Strategic Outlook
  • Table 84 Qiagen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 Qiagen: Product Benchmarking
  • Table 86 Qiagen: Strategic Outlook
  • Table 87 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Quest Diagnostics Incorporated: Product Benchmarking
  • Table 89 Quest Diagnostics Incorporated: Strategic Outlook
  • Table 90 Agilent Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Agilent Technologies Inc.: Product Benchmarking
  • Table 92 Agilent Technologies Inc.: Strategic Outlook
  • Table 93 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 Illumina, Inc.: Product Benchmarking
  • Table 95 Illumina, Inc.: Strategic Outlook
  • Table 96 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Novartis AG: Product Benchmarking
  • Table 98 Novartis AG: Strategic Outlook
  • Table 99 bioMerieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 bioMerieux SA: Product Benchmarking
  • Table 101 bioMerieux SA: Strategic Outlook
  • Table 102 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 103 F. Hoffmann-La Roche Ltd.: Product Benchmarking
  • Table 104 F. Hoffmann-La Roche Ltd.: Strategic Outlook
  • Table 105 Abbott : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 Abbott: Product Benchmarking
  • Table 107 Abbott: Strategic Outlook
  • Table 108 Lilly: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Lilly: Product Benchmarking
  • Table 110 Lilly: Strategic Outlook
  • Table 111 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 113 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 114 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 AstraZeneca: Product Benchmarking
  • Table 116 AstraZeneca: Strategic Outlook
  • Table 117 Myriad Genetics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 Myriad Genetics Inc.: Product Benchmarking
  • Table 119 Myriad Genetics Inc.: Strategic Outlook
  • Table 120 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 121 GSK plc: Product Benchmarking
  • Table 122 GSK plc: Strategic Outlook
  • Table 123 Bristol-Myers Squibb Company Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 124 Bristol-Myers Squibb Company: Product Benchmarking
  • Table 125 Bristol-Myers Squibb Company: Strategic Outlook
  • Table 126 Danaher : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 127 Danaher: Product Benchmarking
  • Table 128 Danaher: Strategic Outlook
  • Table 129 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 130 Laboratory Corporation of America Holdings: Product Benchmarking
  • Table 131 Laboratory Corporation of America Holdings: Strategic Outlook
  • Table 132 GE HealthCare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 133 GE HealthCare: Product Benchmarking
  • Table 134 GE HealthCare: Strategic Outlook
  • Table 135 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 136 Teva Pharmaceutical Industries Ltd.: Product Benchmarking
  • Table 137 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
  • Table 138 NanoString Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 139 NanoString Technologies, Inc.: Product Benchmarking
  • Table 140 NanoString Technologies, Inc.: Strategic Outlook
  • Table 141 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 142 Bayer AG: Product Benchmarking
  • Table 143 Bayer AG: Strategic Outlook
  • Table 144 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 145 Biogen: Product Benchmarking
  • Table 146 Biogen: Strategic Outlook
  • Table 147 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 148 Johnson & Johnson Services, Inc.: Product Benchmarking
  • Table 149 Johnson & Johnson Services, Inc.: Strategic Outlook

List of Figures

  • Figure 1 Precision Medicine Market Segmentation
  • Figure 2 Precision Medicine Market Attractiveness Index by Region
  • Figure 3 Precision Medicine Market by Product Type: Market Attractiveness Index
  • Figure 4 Precision Medicine Market by Application: Market Attractiveness Index
  • Figure 5 Precision Medicine Market by Technology: Market Attractiveness Index
  • Figure 6 Precision Medicine Market by End-users: Market Attractiveness Index
  • Figure 7 Precision Medicine Market: Market Dynamics
  • Figure 8 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %): "V" Shaped Recovery
  • Figure 9 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %): "U" Shaped Recovery
  • Figure 10 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %): "W" Shaped Recovery
  • Figure 11 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %): "L" Shaped Recovery
  • Figure 12 Precision Medicine Market: Porter's Five Forces Analysis
  • Figure 13 Global Precision Medicine Market: SWOT Analysis
  • Figure 14 Precision Medicine Market: PEST Analysis
  • Figure 15 Precision Medicine Market by Product Type: Market Attractiveness Index
  • Figure 16 Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR %)
  • Figure 17 Precision Medicine Market Share Forecast by Product Type, 2023, 2028, 2033 (%)
  • Figure 18 Diagnostics Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 19 Diagnostics Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 20 Genetic Tests Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 21 Genetic Tests Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 22 Biomarker Based Tests Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 23 Biomarker Based Tests Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 24 Others Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 25 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 26 Therapeutics Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 27 Therapeutics Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 28 Precision Medicine Market by Application: Market Attractiveness Index
  • Figure 29 Precision Medicine Market by Application, 2023-2033 (US$ Billion)
  • Figure 30 Precision Medicine Market Share Forecast by Application, 2023, 2028, 2033 (%)
  • Figure 31 Oncology Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 32 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 33 CNS Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 34 CNS Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 35 Immunology Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 36 Immunology Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 37 Respiratory Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 38 Respiratory Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 39 Others Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 40 Others Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 41 Precision Medicine Market by Technology: Market Attractiveness Index
  • Figure 42 Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
  • Figure 43 Precision Medicine Market Share Forecast by Technology, 2023, 2028, 2033 (%)
  • Figure 44 Drug Discovery Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 45 Drug Discovery Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 46 Bioinformatics Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 47 Bioinformatics Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 48 Big Data Analytics Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 49 Big Data Analytics Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 50 Gene Sequencing Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 51 Gene Sequencing Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 52 Companion Diagnostics Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 53 Companion Diagnostics Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 54 Other Technologies Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 55 Other Technologies Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 56 Precision Medicine Market by End-users: Market Attractiveness Index
  • Figure 57 Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
  • Figure 58 Precision Medicine Market Share Forecast by End-users, 2023, 2028, 2033 (%)
  • Figure 59 Hospitals Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 60 Hospitals Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 61 Diagnostic Centres Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 62 Diagnostic Centres Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 63 Research & academic institutes Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 64 Research & academic institutes Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 65 Other End-users Market Forecast by Region, 2023-2033 (US$ Billion)
  • Figure 66 Other End-users Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 67 Precision Medicine Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
  • Figure 68 Precision Medicine Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 69 Precision Medicine Market by Region, 2023-2033 (US$ Billion, AGR %)
  • Figure 70 North America Precision Medicine Market Attractiveness Index
  • Figure 71 North America Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 72 North America Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion, AGR %)
  • Figure 73 North America Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 74 North America Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion, AGR %)
  • Figure 75 North America Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 76 North America Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion, AGR %)
  • Figure 77 North America Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 78 North America Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion, AGR %)
  • Figure 79 North America Precision Medicine Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 80 North America Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion, AGR %)
  • Figure 81 North America Precision Medicine Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 82 U.S. Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 83 Canada Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 84 Europe Precision Medicine Market Attractiveness Index
  • Figure 85 Europe Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 86 Europe Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion)
  • Figure 87 Europe Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 88 Europe Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion)
  • Figure 89 Europe Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 90 Europe Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion)
  • Figure 91 Europe Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 92 Europe Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
  • Figure 93 Europe Precision Medicine Market Share Forecast by Technology, 2023 & 2033(%)
  • Figure 94 Europe Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
  • Figure 95 Europe Precision Medicine Market Share Forecast by End-users, 2023 & 2033(%)
  • Figure 96 Germany Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 97 UK Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 98 France Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 99 Italy Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 100 Spain Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 101 Switzerland Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 102 Netherlands Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 103 Rest of Europe Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 104 Asia Pacific Precision Medicine Market Attractiveness Index
  • Figure 105 Asia Pacific Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 106 Asia Pacific Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion)
  • Figure 107 Asia Pacific Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 108 Asia Pacific Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion)
  • Figure 109 Asia Pacific Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 110 Asia Pacific Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion)
  • Figure 111 Asia Pacific Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 112 Asia Pacific Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
  • Figure 113 Asia Pacific Precision Medicine Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 114 Asia Pacific Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
  • Figure 115 Asia Pacific Precision Medicine Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 116 Japan Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 117 China Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 118 India Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 119 Australia Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 120 South Korea Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 121 Singapore Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 122 Rest of Asia Pacific Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 123 Latin America Precision Medicine Market Attractiveness Index
  • Figure 124 Latin America Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 125 Latin America Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion)
  • Figure 126 Latin America Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 127 Latin America Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion)
  • Figure 128 Latin America Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 129 Latin America Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion)
  • Figure 130 Latin America Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 131 Latin America Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
  • Figure 132 Latin America Precision Medicine Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 133 Latin America Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
  • Figure 134 Latin America Precision Medicine Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 135 Brazil Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 136 Mexico Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 137 Argentina Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 138 Rest of Latin America Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 139 MEA Precision Medicine Market Attractiveness Index
  • Figure 140 MEA Precision Medicine Market by Region, 2023, 2028 & 2033 (US$ Billion)
  • Figure 141 MEA Precision Medicine Market Forecast by Country, 2023-2033 (US$ Billion)
  • Figure 142 MEA Precision Medicine Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 143 MEA Precision Medicine Market Forecast by Product Type, 2023-2033 (US$ Billion)
  • Figure 144 MEA Precision Medicine Market Share Forecast by Product Type, 2023 & 2033 (%)
  • Figure 145 MEA Precision Medicine Market Forecast by Application, 2023-2033 (US$ Billion)
  • Figure 146 MEA Precision Medicine Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 147 MEA Precision Medicine Market Forecast by Technology, 2023-2033 (US$ Billion)
  • Figure 148 MEA Precision Medicine Market Share Forecast by Technology, 2023 & 2033 (%)
  • Figure 149 MEA Precision Medicine Market Forecast by End-users, 2023-2033 (US$ Billion)
  • Figure 150 MEA Precision Medicine Market Share Forecast by End-users, 2023 & 2033 (%)
  • Figure 151 GCC Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 152 South Africa Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 153 Egypt Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 154 Rest of MEA Precision Medicine Market Forecast, 2023-2033 (US$ Billion, AGR %)
  • Figure 155 Precision Medicine Market: Company Share/Ranking, 2022
  • Figure 156 Pfizer Inc. Inc: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 157 Pfizer Inc.: R&D, 2018-2022 (US$ Million, AGR%)
  • Figure 158 Pfizer Inc.: Regional Market Shares, 2022
  • Figure 159 Qiagen: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 160 Qiagen: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 161 Qiagen: Regional Market Shares, 2022
  • Figure 162 Quest Diagnostics Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 163 Agilent Technologies Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 164 Agilent Technologies Inc.: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 165 Agilent Technologies Inc.: Regional Market Shares, 2022
  • Figure 166 Illumina, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR (%)
  • Figure 167 Illumina, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 168 Illumina, Inc.: Regional Market Shares, 2022
  • Figure 169 Novartis AG: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 170 Novartis AG: R&D, 2018-2022(US$ Million, AGR %)
  • Figure 171 Novartis AG: Regional Market Shares, 2022
  • Figure 172 bioMerieux SA: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 173 bioMerieux SA: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 174 bioMerieux SA: Regional Market Shares, 2022
  • Figure 175 F. Hoffmann-La Roche Ltd: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 176 F. Hoffmann-La Roche Ltd: R&D, 2018-2022 (US$ Million, AGR (%))
  • Figure 177 F. Hoffmann-La Roche Ltd: Regional Market Shares, 2022
  • Figure 178 Abbott: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 179 Abbott: R&D, 2018-2022(US$ Million, AGR %)
  • Figure 180 Abbott: Regional Market Shares, 2022
  • Figure 181 Lilly.: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 182 Lilly.: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 183 Lilly.: Regional Market Shares, 2022
  • Figure 184 Thermo Fisher Scientific Inc..: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 185 Thermo Fisher Scientific Inc..: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 186 Thermo Fisher Scientific Inc..: Regional Market Shares, 2022
  • Figure 187 AstraZeneca: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 188 AstraZeneca: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 189 AstraZeneca.: Regional Market Shares, 2021
  • Figure 190 Myriad Genetics Inc.: Net Revenue, 2018-2022(US$ Million, AGR %)
  • Figure 191 Myriad Genetics Inc.: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 192 Myriad Genetics Inc.: Regional Market Shares, 2022
  • Figure 193 GSK plc: Net Revenue, 2018-2022(US$ Million, AGR %)
  • Figure 194 GSK plc: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 195 GSK plc: Regional Market Shares, 2022
  • Figure 196 Bristol-Myers Squibb Company: Net Revenue, 2018-2022(US$ Million, AGR %)
  • Figure 197 Bristol-Myers Squibb Company: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 198 Bristol-Myers Squibb Company: Regional Market Shares, 2022
  • Figure 199 Danaher: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 200 Danaher: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 201 Danaher: Regional Market Shares, 2022
  • Figure 202 Laboratory Corporation of America Holdings: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 203 Laboratory Corporation of America Holdings: Regional Market Shares, 2022
  • Figure 204 GE HealthCare: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 205 GE HealthCare: Regional Market Shares, 2022
  • Figure 206 Teva Pharmaceutical Industries Ltd: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 207 Teva Pharmaceutical Industries Ltd: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 208 Teva Pharmaceutical Industries Ltd: Regional Market Shares, 2022
  • Figure 209 NanoString Technologies, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 210 NanoString Technologies, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 211 NanoString Technologies, Inc.: Regional Market Shares, 2022
  • Figure 212 Bayer AG: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 213 Bayer AG: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 214 Bayer AG: Regional Market Shares, 2022
  • Figure 215 Biogen: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 216 Biogen: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 217 Biogen: Regional Market Shares, 2022
  • Figure 218 Johnson & Johnson Services, Inc.: Net Revenue, 2018-2022 (US$ Million, AGR %)
  • Figure 219 Johnson & Johnson Services, Inc.: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 220 Johnson & Johnson Services, Inc.: Regional Market Shares, 2022
目次
Product Code: PHA1263

The global Precision Medicine market is projected to grow at a CAGR of 11.0% by 2033.

“The Precision Medicine Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Expanding Applications of Precision Medicine and Rising Demand for Targeted Therapy

With regard to genetic disorders, precision medicine is becoming more prevalent. In the domains of neurogenetics, cardiovascular genomics, and rare illness genetic testing, this method is being employed more frequently. Additionally, non-invasive prenatal testing, pharmacogenomics, and screening genetic risk for hereditary diseases are also becoming more prevalent applications of precision medicine. A number of pharmaceutical companies are also concentrating on the creation of precision medicine for neurological conditions like Alzheimer's and Parkinson's disease. Pharmacological, biopharmaceutical, and pharmaceutical firms are continuously working to integrate patient-selection diagnostic frameworks into the earlier phases of drug development in order to deliver targeted therapies to the appropriate candidate and support the expansion of the precision medicine market. One of the main causes of the expanding usage of genomes and proteomics technologies as well as precision medicine is the increased understanding of the advantages of personalised medicine. Individualised treatment plans for many chronic diseases and conditions must include precision medicine, which entails the investigation of specific indications for particular medications in a given patient.

High Cost of Precision Medicine

Although personalized treatments are well-established in the pharmaceutical business, their cost continues to prevent payers, patients, and doctors from accessing them. Despite offering guaranteed returns on investment, the high initial cost of these tests makes them inaccessible to a huge majority of end users, particularly those in poor nations. As a result, end users like pharmaceutical firms, reference labs, medical facilities, and CROs who view the cost of such diagnostic procedures as a burden choose to use third-party precision diagnostic services. Inevitably, current medical privacy and investigation guidelines are inadequate to allow for the collection of enormous amounts of data on large patient populations, and private healthcare systems lack the infrastructure to do so, which drives up the price of precision medicine even more.

What Questions Should You Ask before buying a Market Research Report?

  • How is the precision medicine market evolving?
  • What is driving and restraining the precision medicine market?
  • How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each precision medicine submarket develop from 2022 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading precision medicine markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the precision medicine projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of precision medicine projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the precision medicine market?
  • Where is the precision medicine market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Precision Medicine market today, and over the next 10 years:

  • Our 347-page report provides 149 tables, 220 charts, and graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Precision Medicine market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Precision Medicine prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Product

  • Diagnostic
    • Genetic Tests
    • Biomarker Based Tests
    • Other Diagnostic Tests
  • Therapeutics

Application

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Others

Technology

  • Drug Discovery
  • Bioinformatics
  • Big Data Analytics
  • Gene Sequencing
  • Companion Diagnostics
  • Other Technologies

End-user

  • Hospitals
  • Diagnostic Centres
  • Research & Academic Institutes
  • Other End-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 25 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Egypt
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Precision Medicine Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Abbott
  • Abnova Corporation
  • Agilent Technologies Inc
  • AstraZeneca
  • Bayer AG
  • Biogen
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare
  • GSK plc
  • Illumina, Inc
  • Johnson & Johnson Services, Inc
  • Laboratory Corporation of America Holdings
  • Lilly
  • Myriad Genetics Inc
  • NanoString Technologies, Inc
  • Novartis AG
  • Pfizer Inc
  • Qiagen
  • Quest Diagnostics Incorporated
  • Teva Pharmaceutical Industries Ltd
  • Thermo Fisher Scientific Inc.

Overall world revenue for Precision Medicine Market, 2023 to 2033 in terms of value the market will surpass US$78 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Precision Medicine Market, 2023 to 2033 report help you?

In summary, our 340+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Precision Medicine Market, 2023 to 2033 Market, with forecasts for product, mode, sample, platform, end user, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 25 key national markets - See forecasts for the Precision Medicine Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Switzerland, Netherlands, China, India, Japan, Australia, South Korea, Singapore, Argentina, GCC, South Africa, and Egypt among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Precision Medicine Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Precision Medicine Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Precision Medicine Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Increasing Global Burden of Cancer Boosts the Demand for Personalized Medicine
      • 3.2.1.2 Increase in Scope of Application of Precision Medicine
      • 3.2.1.3 Accelerating Demand for Targeted Therapy
      • 3.2.1.4 Growing Precedence of Precision Medicine Over Traditional Practice of "One-Size-Fits-All" Therapies
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 High Cost of Precision Medicine
      • 3.2.2.2 Lack of Data Interoperability
      • 3.2.2.3 Insufficient Funding for Diagnostics Space in the Emerging Economies
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Growing Use of AI in Healthcare Is Boosting Demand for Precision Medicine
      • 3.2.3.2 Growing acceptance of gene therapy and gene editing technology
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Supplier
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Threat of New Entrants
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Competitive Rivalry
  • 3.5 SWOT Analysis
  • 3.6 PEST Analysis

4 Precision Medicine Market Analysis by Product Type

  • 4.1 Key Findings
  • 4.2 Product Type Segment: Market Attractiveness Index
  • 4.3 Precision Medicine Market Size Estimation and Forecast by Product Type
  • 4.4 Diagnostics
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.3 Genetic Tests
      • 4.4.3.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 4.4.3.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.4 Biomarker Based Tests
      • 4.4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 4.4.4.2 Market Share by Region, 2023 & 2033 (%)
    • 4.4.5 Others
      • 4.4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
      • 4.4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Therapeutics
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Precision Medicine Market, by Application, 2023-2033

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Precision Medicine Market, by Application
  • 5.4 Oncology
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 CNS
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Immunology
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)
  • 5.7 Respiratory
    • 5.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.7.2 Market Share by Region, 2023 & 2033 (%)
  • 5.8 Others
    • 5.8.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 5.8.2 Market Share by Region, 2023 & 2033 (%)

6 Precision Medicine Market, by Technology, 2023-2033

  • 6.1 Key Findings
  • 6.2 Technology Segment: Market Attractiveness Index
  • 6.3 Precision Medicine Market Size Estimation and Forecast by Technology
  • 6.4 Drug Discovery
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Bioinformatics
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Big Data Analytics
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Gene Sequencing
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Companion Diagnostics
    • 6.8.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)
  • 6.9 Other Technologies
    • 6.9.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 6.9.2 Market Share by Region, 2023 & 2033 (%)

7 Precision Medicine Market, by End-users, 2023-2033

  • 7.1 Key Findings
  • 7.2 End-users Segment: Market Attractiveness Index
  • 7.3 Precision Medicine Market Size Estimation and Forecast by End-users
  • 7.4 Hospitals
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Diagnostic centres
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)
  • 7.6 Research & Academic Institutes
    • 7.6.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.6.2 Market Share by Region, 2023 & 2033 (%)
  • 7.7 Other End-users
    • 7.7.1 Market Size by Region, 2023-2033 (US$ Billion)
    • 7.7.2 Market Share by Region, 2023 & 2033 (%)

8 Precision Medicine Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Precision Medicine Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Precision Medicine Market Attractiveness Index
  • 9.3 North America Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 9.4 North America Precision Medicine Market Size Estimation and Forecast by Country
  • 9.5 North America Precision Medicine Market Size Estimation and Forecast by Product Type
  • 9.6 North America Precision Medicine Market Size Estimation and Forecast by Application
  • 9.7 North America Precision Medicine Market Size Estimation and Forecast by Technology
  • 9.8 North America Precision Medicine Market Size Estimation and Forecast by End-users
  • 9.9 U.S. Precision Medicine Market Analysis
  • 9.10 Canada Precision Medicine Market Analysis

10 Europe Precision Medicine Market, 2023-2033

  • 10.1 Key Findings
  • 10.2 Europe Precision Medicine Market Attractiveness Index
  • 10.3 Europe Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 10.4 Europe Precision Medicine Market Size Estimation and Forecast by Country
  • 10.5 Europe Precision Medicine Market Size Estimation and Forecast by Product Type
  • 10.6 Europe Precision Medicine Market Size Estimation and Forecast by Application
  • 10.7 Europe Precision Medicine Market Size Estimation and Forecast by Technology
  • 10.8 Europe Precision Medicine Market Size Estimation and Forecast by End-users
  • 10.9 Germany Precision Medicine Market Analysis
  • 10.10 UK Precision Medicine Market Analysis
  • 10.11 France Precision Medicine Market Analysis
  • 10.12 Italy Precision Medicine Market Analysis
  • 10.13 Spain Precision Medicine Market Analysis
  • 10.14 Switzerland Precision Medicine Market Analysis
  • 10.15 Netherlands Precision Medicine Market Analysis
  • 10.16 Rest of Europe Precision Medicine Market Analysis

11 Asia Pacific Precision Medicine Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Precision Medicine Market Attractiveness Index
  • 11.3 Asia Pacific Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 11.4 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Product Type
  • 11.6 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Application
  • 11.7 Asia Pacific Precision Medicine Market Size Estimation and Forecast by Technology
  • 11.8 Asia Pacific Precision Medicine Market Size Estimation and Forecast by End-users
  • 11.9 Japan Precision Medicine Market Analysis
  • 11.10 China Precision Medicine Market Analysis
  • 11.11 India Precision Medicine Market Analysis
  • 11.12 Australia Precision Medicine Market Analysis
  • 11.13 South Korea Precision Medicine Market Analysis
  • 11.14 Singapore Precision Medicine Market Analysis
  • 11.15 Rest of Asia Pacific Precision Medicine Market Analysis

12 Latin America Precision Medicine Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Precision Medicine Market Attractiveness Index
  • 12.3 Latin America Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 12.4 Latin America Precision Medicine Market Size Estimation and Forecast by Country
  • 12.5 Latin America Precision Medicine Market Size Estimation and Forecast by Product Type
  • 12.6 Latin America Precision Medicine Market Size Estimation and Forecast by Application
  • 12.7 Latin America Precision Medicine Market Size Estimation and Forecast by Technology
  • 12.8 Latin America Precision Medicine Market Size Estimation and Forecast by End-users
  • 12.9 Brazil Precision Medicine Market Analysis
  • 12.10 Mexico Precision Medicine Market Analysis
  • 12.11 Argentina Precision Medicine Market Analysis
  • 12.12 Rest of Latin America Precision Medicine Market Analysis

13 MEA Precision Medicine Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Precision Medicine Market Attractiveness Index
  • 13.3 MEA Precision Medicine Market by Country, 2023, 2028 & 2033 (US$ Billion)
  • 13.4 MEA Precision Medicine Market Size Estimation and Forecast by Country
  • 13.5 MEA Precision Medicine Market Size Estimation and Forecast by Product Type
  • 13.6 MEA Precision Medicine Market Size Estimation and Forecast by Application
  • 13.7 MEA Precision Medicine Market Size Estimation and Forecast by Technology
  • 13.8 MEA Precision Medicine Market Size Estimation and Forecast by End-users
  • 13.9 GCC Precision Medicine Market Analysis
  • 13.10 South Africa Precision Medicine Market Analysis
  • 13.11 Egypt Precision Medicine Market Analysis
  • 13.12 Rest of MEA Precision Medicine Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2022
  • 14.2 Pfizer Inc.
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2018-2022
      • 14.2.3.2 R&D, 2018-2022
      • 14.2.3.3 Regional Market Shares, 2022
    • 14.2.4 Product Benchmarking
    • 14.2.5 Strategic Outlook
  • 14.3 Qiagen
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2018-2022
      • 14.3.3.2 R&D, 2018-2022
      • 14.3.3.3 Regional Market Shares, 2022
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Quest Diagnostics Incorporated
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Net Revenue, 2018-2022
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
  • 14.5 Agilent Technologies Inc.
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2018-2022
      • 14.5.3.2 R&D, 2018-2022
      • 14.5.3.3 Regional Market Shares, 2022
    • 14.5.4 Product Benchmarking
    • 14.5.5 Strategic Outlook
  • 14.6 Illumina, Inc.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2018-2022
      • 14.6.3.2 R&D, 2018-2022
      • 14.6.3.3 Regional Market Shares, 2022
    • 14.6.4 Product Benchmarking
    • 14.6.5 Strategic Outlook
  • 14.7 Novartis AG
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2018-2022
      • 14.7.3.2 R&D, 2018-2022
      • 14.7.3.3 Regional Market Shares, 2022
    • 14.7.4 Product Benchmarking
    • 14.7.5 Strategic Outlook
  • 14.8 bioMerieux SA
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Financial Analysis
      • 14.8.3.1 Net Revenue, 2018-2022
      • 14.8.3.2 R&D, 2018-2022
      • 14.8.3.3 Regional Market Shares, 2022
    • 14.8.4 Product Benchmarking
    • 14.8.5 Strategic Outlook
  • 14.9 F. Hoffmann-La Roche Ltd
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2018-2022
      • 14.9.3.2 R&D, 2018-2022
      • 14.9.3.3 Regional Market Shares, 2022
    • 14.9.4 Product Benchmarking
    • 14.9.5 Strategic Outlook
  • 14.10 Abbott
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2018-2022
      • 14.10.3.2 R&D, 2018-2022
      • 14.10.3.3 Regional Market Shares, 2022
    • 14.10.4 Product Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Lilly
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2018-2022
      • 14.11.3.2 R&D, 2018-2022
      • 14.11.3.3 Regional Market Shares, 2022
    • 14.11.4 Product Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 Thermo Fisher Scientific Inc.
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2018-2022
      • 14.12.3.2 R&D, 2018-2022
      • 14.12.3.3 Regional Market Shares, 2022
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 AstraZeneca
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2018-2022
      • 14.13.3.2 R&D, 2018-2022
      • 14.13.3.3 Regional Market Shares, 2022
    • 14.13.4 Product Benchmarking
    • 14.13.5 Strategic Outlook
  • 14.14 Myriad Genetics Inc
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis
      • 14.14.3.1 Net Revenue, 2018-2022
      • 14.14.3.2 R&D, 2018-2022
      • 14.14.3.3 Regional Market Shares, 2022
    • 14.14.4 Product Benchmarking
    • 14.14.5 Strategic Outlook
  • 14.15 GSK plc
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2018-2022
      • 14.15.3.2 R&D, 2018-2022
      • 14.15.3.3 Regional Market Shares, 2022
    • 14.15.4 Product Benchmarking
    • 14.15.5 Strategic Outlook
  • 14.16 Bristol-Myers Squibb Company
    • 14.16.1 Company Snapshot
    • 14.16.2 Company Overview
    • 14.16.3 Financial Analysis
      • 14.16.3.1 Net Revenue, 2018-2022
      • 14.16.3.2 R&D, 2018-2022
      • 14.16.3.3 Regional Market Shares, 2022
    • 14.16.4 Product Benchmarking
    • 14.16.5 Strategic Outlook
  • 14.17 Danaher
    • 14.17.1 Company Snapshot
    • 14.17.2 Company Overview
    • 14.17.3 Financial Analysis
      • 14.17.3.1 Net Revenue, 2018-2022
      • 14.17.3.2 R&D, 2018-2022
      • 14.17.3.3 Regional Market Shares, 2022
    • 14.17.4 Product Benchmarking
    • 14.17.5 Strategic Outlook
  • 14.18 Laboratory Corporation of America Holdings
    • 14.18.1 Company Snapshot
    • 14.18.2 Company Overview
    • 14.18.3 Financial Analysis
      • 14.18.3.1 Net Revenue, 2018-2022
      • 14.18.3.2 Regional Market Shares, 2022
    • 14.18.4 Product Benchmarking
    • 14.18.5 Strategic Outlook
  • 14.19 GE HealthCare
    • 14.19.1 Company Snapshot
    • 14.19.2 Company Overview
    • 14.19.3 Financial Analysis
      • 14.19.3.1 Net Revenue, 2018-2022
      • 14.19.3.2 Regional Market Shares, 2022
    • 14.19.4 Product Benchmarking
    • 14.19.5 Strategic Outlook
  • 14.20 Teva Pharmaceutical Industries Ltd.
    • 14.20.1 Company Snapshot
    • 14.20.2 Company Overview
    • 14.20.3 Financial Analysis
      • 14.20.3.1 Net Revenue, 2018-2022
      • 14.20.3.2 R&D, 2018-2022
      • 14.20.3.3 Regional Market Shares, 2022
    • 14.20.4 Product Benchmarking
    • 14.20.5 Strategic Outlook
  • 14.21 NanoString Technologies, Inc.
    • 14.21.1 Company Snapshot
    • 14.21.2 Company Overview
    • 14.21.3 Financial Analysis
      • 14.21.3.1 Net Revenue, 2018-2022
      • 14.21.3.2 R&D, 2018-2022
      • 14.21.3.3 Regional Market Shares, 2022
    • 14.21.4 Product Benchmarking
    • 14.21.5 Strategic Outlook
  • 14.22 Bayer AG
    • 14.22.1 Company Snapshot
    • 14.22.2 Company Overview
    • 14.22.3 Financial Analysis
      • 14.22.3.1 Net Revenue, 2018-2022
      • 14.22.3.2 R&D, 2018-2022
      • 14.22.3.3 Regional Market Shares, 2022
    • 14.22.4 Product Benchmarking
    • 14.22.5 Strategic Outlook
  • 14.23 Biogen
    • 14.23.1 Company Snapshot
    • 14.23.2 Company Overview
    • 14.23.3 Financial Analysis
      • 14.23.3.1 Net Revenue, 2018-2022
      • 14.23.3.2 R&D, 2018-2022
      • 14.23.3.3 Regional Market Shares, 2022
    • 14.23.4 Product Benchmarking
    • 14.23.5 Strategic Outlook
  • 14.24 Johnson & Johnson Services, Inc.
    • 14.24.1 Company Snapshot
    • 14.24.2 Company Overview
    • 14.24.3 Financial Analysis
      • 14.24.3.1 Net Revenue, 2018-2022
      • 14.24.3.2 R&D, 2018-2022
      • 14.24.3.3 Regional Market Shares, 2022
    • 14.24.4 Product Benchmarking
    • 14.24.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from
  • 15.2 Recommendations for Market Players